Healio

Discontinuing ICS therapy in COPD hastens decline in lung function

Lung function decline quickened during a 5-year follow-up in patients with moderate to severe COPD who ceased use of or sporadically maintained inhaled corticosteroid treatment after 30 months of ...
European Medical Journal

COPD Treatment Withdrawal Raises Early Exacerbation Risk

New trial analysis shows COPD treatment withdrawal, including LAMA and ICS discontinuation, can trigger early exacerbation ...
Monthly Prescribing Reference

Does Adding LABA/ICS to Tiotropium Improve COPD Outcomes?

A Cochrane systematic review has found new moderate-quality evidence that tiotropium + long-acting beta2-agonist/inhaled corticosteroid (LABA/ICS) combination therapy reduces hospital admission for ...
Medscape

Maintenance ICS Use in Severe COPD: Will It Reduce Exacerbations?

Many patients with moderately severe or worse chronic obstructive pulmonary disease (COPD) are receiving an inhaled corticosteroid (ICS) in addition to a long-acting beta-agonist (LABA) and/or a ...
The American Journal of Managed Care

LAMA-LABA Therapy Provides Improved Outcomes in COPD Over ICS-LABA

The findings provide further support of recommendations in the clinical guidelines to favor one therapy over the other. Patients with chronic obstructive pulmonary disease (COPD) being treated with ...
The American Journal of Managed Care

For COPD Treated in Primary Care, ICS May Be Inappropriately Prescribed

Inhaled corticosteroid (ICS) therapy was not the most appropriate treatment for many patients with chronic obstructive pulmonary disease (COPD) in a review of patient records at 2 US primary care ...
MedPage Today

Efforts Needed to De-Escalate Use of Inhaled Corticosteroids in COPD

Interventions to de-escalate use of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD) are necessary and beneficial, researchers said during the federal ...
Healio

Discontinuing ICS use in COPD reduces risk for pneumonia

Please provide your email address to receive an email when new articles are posted on . Patients with COPD who discontinued using inhaled corticosteroids experienced a more than 25% decrease in the ...
Medscape

Effects of ICS Discontinuation in COPD Patients on Triple Therapy

Findings support the most recent Global Initiative for Chronic Obstructive Lung Disease recommendations and the European Respiratory Society Task Force report on ICS withdrawal in COPD. The study ...
Monthly Prescribing Reference

ICS Use in COPD Associated With Lower Pneumonia-Related, Overall Mortality

Treatment with inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD) may reduce the risk of death from pneumonia and other causes although they are associated an ...
Medical Xpress

Inhaled corticosteroids for COPD decrease mortality risk from pneumonia and other causes

Treatment of COPD with inhaled corticosteroids (ICS) may decrease the risk of dying from pneumonia and from other causes despite being associated with an increase in the occurrence of pneumonia, ...
News Medical

ICS overuse warning in COPD

Researchers from the UK caution that inhaled corticosteroids (ICS) are being overused in patients with chronic obstructive pulmonary disease (COPD), in light of a lack of solid evidence for their ...